1
项与 Allogeneic limbal stromal stem cells(L.V. Prasad Eye Institute) 相关的临床试验A Proof of Concept Study to Evaluate the Clinical Safety and Efficacy of Ex-vivo Cultivated Allogenic Limbal Stem Cell Transplantation for Treatment of Superficial Corneal Pathologies".
This study proposes to investigate the transplantation of ex-vivo cultivated allogenic limbal stromal cells for the treatment of the corneal pathologies. The limbus is an ideal source as the stem cells are numerous and located very superficially in the tissue (17). Pre-clinical work suggests human corneal stromal stem cells can be isolated from the cadaveric tissues, cultivated in conditions suitable for cell based therapy and used to prevent fibrosis in a murine model of corneal stromal scarring. Further, these cells are able to successfully engraft, differentiate, and mediate wound healing in the corneal stroma such that the tissue remains healthy, free of fibrotic tissue, and optically transparent. The clinical implications of these findings are substantial in that it represents the potential to lessen the burden on donor tissue necessary for corneal allografts by using cultured cells to regenerate tissue. We foresee the ability of a clinician to and grow and expand the cells in number and after surgically removing the scar tissue from the wounded eye, apply the cultured limbal stem cells to regenerate healthy, transparent tissue.
100 项与 Allogeneic limbal stromal stem cells(L.V. Prasad Eye Institute) 相关的临床结果
100 项与 Allogeneic limbal stromal stem cells(L.V. Prasad Eye Institute) 相关的转化医学
100 项与 Allogeneic limbal stromal stem cells(L.V. Prasad Eye Institute) 相关的专利(医药)
100 项与 Allogeneic limbal stromal stem cells(L.V. Prasad Eye Institute) 相关的药物交易